Atlas FDA

TANDEM(R)-E AFP

FDA premarket approval P840035/S003 · decided 1988-04-29

Approval details

PMA number
P840035
Supplement
S003
Supplement type
Panel Track
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
TANDEM(R)-E AFP
Generic name
KIT, TEST,ALPHA-FETOPROTEIN FOR TESTICULAR CANCER
Applicant
Beckman Coulter, Inc.
Date received
1986-04-03
Decision date
1988-04-29
Days to decision
757 days
Decision code
APPR
Product code
LOJ
Advisory committee
Immunology
Expedited review
No
Location
San Diego, CA

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Access BNP II (K252169)Beckman Coulter, Inc.2026-03-24
Access anti-HBc IgM (K254059)Beckman Coulter, Inc.2026-03-13
Access anti-HBc Total (K253687)Beckman Coulter, Inc.2026-02-19
Access anti-HAV IgM (K251995)Beckman Coulter, Inc.2026-01-27
Access Rubella IgG (K250588)Beckman Coulter, Inc.2025-11-17
iQ200 Series (K252580)Beckman Coulter, Inc.2025-09-10
Access anti-HAV (K243846)Beckman Coulter, Inc.2025-09-09
MicroScan Dried Gram-Negative MIC/Combo Panels with Cefepime (CPE) (0.12-64 µg/mL) (MicroScan) (K243804)Beckman Coulter, Inc.2025-08-20